<VariationArchive VariationID="997110" VariationName="NM_000297.4(PKD2):c.1998_2001del (p.Phe666fs)" VariationType="Deletion" Accession="VCV000997110" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2021-02-20" MostRecentSubmission="2022-10-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="984843" VariationID="997110">
      <GeneList>
        <Gene Symbol="PKD2" FullName="polycystin 2, transient receptor potential cation channel" GeneID="5311" HGNC_ID="HGNC:9009" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="88007635" stop="88077777" display_start="88007635" display_stop="88077777" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="88928798" stop="88998930" display_start="88928798" display_stop="88998930" Strand="+" />
          </Location>
          <OMIM>173910</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000297.4(PKD2):c.1998_2001del (p.Phe666fs)</Name>
      <CanonicalSPDI>NC_000004.12:88058079:TTCTTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="88058080" stop="88058083" display_start="88058080" display_stop="88058083" variantLength="4" positionVCF="88058079" referenceAlleleVCF="GTTCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="88979232" stop="88979235" display_start="88979232" display_stop="88979235" variantLength="4" referenceAllele="GTTCT" alternateAllele="G" positionVCF="88979231" referenceAlleleVCF="GTTCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F666fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.88979234_88979237del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.88979234_88979237del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.88058082_88058085del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.88058082_88058085del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008604.1" sequenceAccession="NG_008604" sequenceVersion="1" change="g.55415_55418del">
            <Expression>NG_008604.1:g.55415_55418del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000297.4" sequenceAccession="NM_000297" sequenceVersion="4" change="c.1998_2001del" MANESelect="true">
            <Expression>NM_000297.4:c.1998_2001del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000288.1" sequenceAccession="NP_000288" sequenceVersion="1" change="p.Phe666fs">
            <Expression>NP_000288.1:p.Phe666fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1720431219" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000297.4(PKD2):c.1998_2001del (p.Phe666fs) AND Polycystic kidney disease" Accession="RCV001292010" Version="3">
        <ClassifiedConditionList TraitSetID="8312">
          <ClassifiedCondition DB="MedGen" ID="C0022680">Polycystic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000297.4(PKD2):c.1998_2001del (p.Phe666fs) AND Polycystic kidney disease 2" Accession="RCV002290682" Version="3">
        <ClassifiedConditionList TraitSetID="3718">
          <ClassifiedCondition DB="MedGen" ID="C2751306">Polycystic kidney disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-12" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-02-20" MostRecentSubmission="2022-10-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3718" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6943" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE II</ElementValue>
                <XRef Type="MIM" ID="613095" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease 2</ElementValue>
                <XRef ID="MONDO:0013131" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE</ElementValue>
                <XRef Type="MIM" ID="613095" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">APKD2</ElementValue>
                <XRef Type="MIM" ID="613095" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PKD2</ElementValue>
                <XRef Type="MIM" ID="613095" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18599" />
                <XRef ID="18599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <XRef ID="C2751306" DB="MedGen" />
              <XRef ID="MONDO:0013131" DB="MONDO" />
              <XRef Type="MIM" ID="613095" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8312" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="17137" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease</ElementValue>
                <XRef ID="MONDO:0020642" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kidney, Polycystic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney dysplasia</ElementValue>
                <XRef ID="HP:0000113" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7419" />
                <XRef ID="7419" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0022680" DB="MedGen" />
              <XRef ID="D007690" DB="MeSH" />
              <XRef ID="MONDO:0020642" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000113" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004716" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004739" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004740" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008645" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008673" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008699" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2918453" SubmissionDate="2021-02-03" DateLastUpdated="2021-02-20" DateCreated="2021-02-20">
        <ClinVarSubmissionID localKey="chr4:88979230-88979235:7b976e08a7115a576dd8e8e1588e499f-PKD" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001481061" DateUpdated="2021-02-20" DateCreated="2021-02-20" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PKD2 p.Phe666LeufsX7 variant was identified in 2 of 582 proband chromosomes (frequency: 0.003) from individuals or families with PKD (Magistroni 2003, Hwang 2016). The variant was also identified in LOVD 3.0 (1x) and ADPKD Mutation Database (1x, Definitely Pathogenic). The variant was not identified in dbSNP, ClinVar, Clinvitae, or the PKD1-LOVD databases. The variant was also not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.1998_2001delCTTT variant is predicted to cause a frameshift, which alters the protein amino acid sequence beginning at codon 666 and leads to a premature stop codon at position 672. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the PKD2 gene are an established mechanism of disease in autosomal dominant polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="4" alternateAllele="G" referenceAllele="GTTCT" start="88979231" stop="88979235" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Polycystic Kidney disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9024014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5043973" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000297.4:c.1998_2001del|OMIM:613095" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002580452" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000297.4:c.1998_2001del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613095" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4_MOD, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5043973" TraitType="Disease" MappingType="XRef" MappingValue="613095" MappingRef="OMIM">
        <MedGen CUI="C2751306" Name="Polycystic kidney disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2918453" TraitType="Disease" MappingType="Name" MappingValue="Polycystic Kidney disease" MappingRef="Preferred">
        <MedGen CUI="C0022680" Name="Polycystic kidney disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

